Research Paper Volume 13, Issue 13 pp 17607—17628
Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma
Figure 4. Evaluating the predictive power of the lncRNA signature in the training cohort. (A–C) Distribution of risk score, survival status, and lncRNA expression of patients in the training cohort; (D) Kaplan-Meier survival curve of the high-risk and low-risk groups in the training cohort; (E) time-dependent ROC curves and AUC based on the training cohort for 1-year, 3-year, and 5-year overall survival; (F) forest plot for multivariate Cox regression analysis.